Email this article The development of system of professional information about pharmaceuticals: Quo vadis?
- Authors: Alyautdin R.N.1, Romanov B.K1
-
Affiliations:
- The Research center of expertise of means of medical application
- Issue: Vol 22, No 3 (2016)
- Pages: 162-165
- Section: Articles
- URL: https://ogarev-online.ru/0869-2106/article/view/38357
- DOI: https://doi.org/10.18821/0869-2106-2016-22-4-162-165
- ID: 38357
Cite item
Full Text
Abstract
The modern technologies provide broad possibilities for acquiring information about pharmaceuticals. However, reliability of this data has no guarantee. The document about pharmaceutical developed by manufacturer and regulatory authorities is taken very often for the source of official information. The quality of content of these documents is criticized by professional community. In the European Union it is taken for trusting the short characteristic of product (SmPC) that is an official source of information about pharmaceutical. The review presents sections of SmPC criticized more often.
Full Text
##article.viewOnOriginalSite##About the authors
Renad N. Alyautdin
The Research center of expertise of means of medical application
Email: аlyautdin@expmed.ru
vice-director of the center of expertise of safety of pharmaceuticals 127051, Moscow, Russia
B. K Romanov
The Research center of expertise of means of medical application127051, Moscow, Russia
References
- Аляутдин Р.Н., Романов Б.К., Переверзев А.П., Бунятян Н.Д. Электронная система выписывания рецептов и безопасность лекарственной терапии. Ведомости Научного центра экспертизы средств медицинского применения. 2014; (2): 30-3.
- Директива 2001/83/ЕС Европейского Парламента и Совета ЕС. Available at: http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf.
- Директива ЕС2010/84/EU5 Европейского Парламента и Совета EC. Available at: http://ec.europa.eu/health/files/eudralex/vol-1/dir_2010_84/dir_2010_84_en.pdf.
- Vromans L., Doyle G., Petak-Opel S., Rödiger A., Röttgermann M., Schlüssel E. Shaping medicinal product information: a before and after study exploring physicians’ perspectives on the summary of product characteristics. BMJ Open. 2013; 3(8): e003033.
- Colaceci S., Giusti A., Chapin E.M., Notarangelo M., De Angelis A., Vellone E. et al. The Difficulties in Antihypertensive Drug Prescription During Lactation: Is the Information Consistent? Breast feed. Med. 2015; 10: 468-72.
- Arguello B., Salgado T. Assessing the information in the Summaries of Product Characteristics for the use of 1 medicines in pregnancy and lactation. Br. J. Clin. Pharmacol. 2015; 79(3): 537-44.
- Dzioba U., Staczak A. Summary of product characteristics (SmPC) n study on utilization of information presented in smpc by different groups of physicians. Acta Pol. Pharm. 2012; 69(2): 341-6.
- Maxwell S., Eichler H.G., Bucsics A., Haefeli W.E., Gustafsson L.L.; e-SPC Consortium. E-SPC delivering drug information in the 21th century: developing new approach to deliver drug information to prescribers. Br. J. Clin. Pharmacol. 2011; 73(1): 12-5.
- Bergk V., Haefeli W.E., Gasse C., Brenner H., Martin-Facklam M. Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature. Eur. J. Clin. Pharmacol. 2005; 61(5-6): 327-35.
- San Miguel M.T., Martínez J.A., Vargas E. Food-drug interactions in the summary of product characteristics of proprietary medicinal products. Eur. J. Clin. Pharmacol. 2005; 61(2): 77-83.
- Salgado T.M., Arguello B., Martinez-Martinez F., Benrimoj S.I., Fernandez-Llimos F. Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment. Eur. J. Clin. Pharmacol. 2013; 69(11): 1973-9.
Supplementary files
